QNTM
NASDAQ · Pharmaceuticals
Quantum Biopharma-B Sub Vot
$4.71
-0.02 (-0.42%)
Open$4.83
Previous Close$4.73
Day High$5.65
Day Low$4.21
52W High$52.00
52W Low$2.85
Volume—
Avg Volume31.5K
Market Cap13.09M
P/E Ratio—
EPS$-10.32
SectorPharmaceuticals
Analyst Ratings
Strong Buy
7 analysts
Price Target
+101.3% upside
Current
$4.71
$4.71
Target
$9.48
$9.48
$6.03
$9.48 avg
$10.62
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 10.42M | 7.61M | 6.92M |
| Net Income | -380,383,734 | 1.84M | 1.19M |
| Profit Margin | -19,353.5% | 24.2% | 17.2% |
| EBITDA | -320,137,952 | 2.64M | 2.30M |
| Free Cash Flow | — | 1.03M | 1.07M |
| Rev Growth | — | +16.6% | +5.5% |
| Debt/Equity | 0.02 | 0.64 | 0.65 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $916.31 | +1.47% | 46.4 | 957.52B |
| JNJ | Johnson & Johnson | $239.93 | +1.98% | 22.2 | 594.00B |
| MRK | Merck & Co. Inc. | $119.37 | +2.58% | 16.5 | 301.17B |
| PFE | Pfizer Inc. | $27.28 | +1.19% | 19.7 | 153.36B |
| BMY | Bristol-Myers Squibb Co | $58.94 | +2.70% | 16.5 | 116.58B |
| ZTS | Zoetis Inc | $116.71 | +0.67% | 21.5 | 57.37B |